|
⚲
|
| Keyboard |
| DCVC Opportunity Fund II LP
✚
|
|
|---|---|
| CIK # | 0001668344 |
| EDGAR Form | CIK | 2011 - 2026 |
|---|---|---|
| 3 | [0001668344] | |
| 4 | [0001668344] | |
| D | [0001668344] |
| Insider Transaction (Form 3/4/5) | Date | Action | Shares | Price | Value ($) |
|---|---|---|---|---|---|
|
Recursion Pharmaceuticals Inc RXRX
Common Stock
|
2021-04-20 | Conversion | 5,941,120 | ||
|
Recursion Pharmaceuticals Inc RXRX
Common Stock
|
2021-04-20 | Other | 5,941,120 | ||
|
Recursion Pharmaceuticals Inc RXRX
Class A Common Stock
|
2021-04-20 | Other | 5,941,120 | ||
|
Recursion Pharmaceuticals Inc RXRX
Common Stock
|
2021-04-20 | Conversion | 3,951,141 | ||
|
Recursion Pharmaceuticals Inc RXRX
Common Stock
|
2021-04-20 | Other | 3,951,141 | ||
|
Recursion Pharmaceuticals Inc RXRX
Class A Common Stock
|
2021-04-20 | Other | 3,951,141 | ||
|
Recursion Pharmaceuticals Inc RXRX
Common Stock
|
2021-04-20 | Conversion | 3,726,963 | ||
|
Recursion Pharmaceuticals Inc RXRX
Common Stock
|
2021-04-20 | Other | 3,726,963 | ||
|
Recursion Pharmaceuticals Inc RXRX
Class A Common Stock
|
2021-04-20 | Other | 3,726,963 | ||
|
Recursion Pharmaceuticals Inc RXRX
Series B Preferred Stock · derivative
|
2021-04-20 | Conversion | 3,220,788 | $0.00 | |
|
Recursion Pharmaceuticals Inc RXRX
Series B Preferred Stock · derivative
|
2021-04-20 | Conversion | 1,073,595 | $0.00 | |
|
Recursion Pharmaceuticals Inc RXRX
Series A Preferred Stock · derivative
|
2021-04-20 | Conversion | 3,771,996 | $0.00 | |
|
Recursion Pharmaceuticals Inc RXRX
Series C Preferred Stock · derivative
|
2021-04-20 | Conversion | 730,353 | $0.00 | |
|
Recursion Pharmaceuticals Inc RXRX
Series C Preferred Stock · derivative
|
2021-04-20 | Conversion | 1,095,529 | $0.00 | |
|
Recursion Pharmaceuticals Inc RXRX
Series D Preferred Stock · derivative
|
2021-04-20 | Conversion | 3,726,963 | $0.00 |